Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Gyre Therapeutics
(L9S.F) Q2 2026
Earnings
L9S.F
May 7
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.09
-0.04
-0
0.04
Details
Expected EPS
-0.06252884910999999
Actual EPS
-0.08526700000000001
Surprise EPS
-0.02
Surprise Percent
-36.36%
Description
Gyre Therapeutics (L9S.F) has reported earnings of -0.08526700000000001 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login